Phototherapeutic keratectomy (PTK) — lasting relief from corneal pain
Phototherapeutic keratectomy (PTK) is a 193 nm excimer laser procedure that treats superficial corneal disorders. Its two main indications are recurrent corneal erosions (RCE) — painful episodes that typically occur on waking — and Cogan / map-dot-fingerprint (MDF) epithelial dystrophy, an abnormality of the epithelial basement membrane.
When conservative treatments (bandage contact lenses, artificial tears, debridement, punctal plugs) have not been enough after several months of proper use, PTK provides lasting improvement. It is an outpatient procedure (5–10 min under topical anesthesia); around 80 to 90% of successfully treated eyes remain recurrence-free at 5 years in published series (Lee 2016, Miller 2019 — Clin Ophthalmol).
PTK — a precise laser ablation
Phototherapeutic keratectomy is a laser technique that removes abnormal superficial layers of the cornea to restore epithelial adhesion and eliminate chronic pain. Understanding how it works helps you make your treatment choice.
Superficial laser ablation
Removing 5–15 µm of cornea (epithelium ± Bowman's layer ± anterior stroma) with a 193 nm excimer laser. The ablation is extremely precise: ablation depth = 0.25 µm per pulse. This allows the epithelial basement membrane to be rebuilt.
Different goals
LASIK/PRK = correcting refractive errors (myopia, hyperopia, astigmatism) by stromal ablation. PTK = treating a superficial disorder (RCE, Cogan) without refractive correction, unless combined with PRK.
Restoring adhesion
Removing the abnormal epithelium stimulates the regeneration of a new, solid basement membrane and better cell adhesion. Fewer recurrences, because the attachments are restored.
Micrometric (<0.5 µm)
The 193 nm excimer laser works spot by spot (spot scanning) with reproducibility < 0.25 µm. Ablation depth is controlled to the micron.
Recurrent corneal erosions (RCE) — morning eye pain
RCE is a condition that is often disruptive in daily life, characterized by recurrent episodes of eye pain on waking. It is the classic and most common indication for PTK.
Clinical definition
Spontaneous breakdown of the epithelium when the eyelids open in the morning, with intense pain, tearing, photophobia and blurred vision. Episodes last anywhere from a few minutes to several hours. The pain can be debilitating and affect quality of life and sleep.
Typical signs
- Intense eye pain on waking (scratching, burning)
- Marked reflex tearing
- Photophobia (sensitivity to light)
- Temporary blurred vision
- Frequency: typically 2–5 recurrences per week
- Duration: from minutes to hours
Causes of RCE
- Post-traumatic (~50%) — fingernails, branches, paper cuts, accidental injury (Reidy 2000, Miller 2019)
- Epithelial dystrophies (~30%) — mainly Cogan / map-dot-fingerprint, more rarely Reis-Bücklers
- Idiopathic or other (~15–20%) — no cause found, or rarer contexts (severe dry eye, after chemical injury)
Impact on daily life
Beyond the morning pain, patients often describe dreading waking up, difficulty falling asleep for fear of the next attack, and generally disturbed sleep. Time off work is common on the days of an attack.
Conservative treatment (before PTK)
Before PTK is offered, all conservative treatments should be tried for ≥3 months:
- Bandage contact lens (soft therapeutic contact lens) — first-line
- Hypotonic artificial tears morning, midday and evening + thickening gel at night
- Hypertonic saline (5% NaCl) in the evening
- Mechanical epithelial debridement (if fibrinous fibrils are visible)
- Punctal plugs if dry eye is also present
- Topical NSAIDs (diclofenac, ketorolac) regularly
Clear indication if: properly conducted conservative measures have failed (bandage lens for 3+ months, tears + night gel, debridement, plugs if indicated), frequent recurrences despite optimal treatment, confirmed epithelial dystrophy, and the patient requests it after being fully informed.
Cogan / map-dot-fingerprint dystrophy — a congenital basement membrane abnormality
Cogan epithelial dystrophy is the most common superficial corneal abnormality. It may remain silent or cause visual symptoms and pain that can be treated effectively with PTK.
What is Cogan dystrophy?
Also known as: epithelial basement membrane dystrophy (EBMD), Cogan microcystic dystrophy.
Definition: a congenital (or degenerative) structural abnormality of the epithelial basement membrane and the basal epithelial layer. It is characterized by:
- Fingerprint patterns — branching lines resembling fingerprints
- Map patterns — map-like, geographic areas
- Dot patterns — dot-like intraepithelial microcysts
Epidemiology
Prevalence varies between studies (up to 6–10% of the general population on systematic slit-lamp examination, Werblin 1981; Laibson). Most carriers remain asymptomatic. Both eyes are frequently involved, often asymmetrically in clinical terms.
Diagnosis
- Slit lamp with retroillumination (shows the typical patterns)
- Anterior segment OCT (irregular epithelial thickness, reduplicated basement membrane)
- Corneal topography (irregular astigmatism, topographic variations)
Varied symptoms
Most patients are asymptomatic and discover the condition by chance. When it is symptomatic, however:
- Recurrent corneal erosions (see previous section)
- Fluctuating vision — variable epithelial distortion = intermittent irregular astigmatism
- Mild chronic foreign body sensation
- Moderate photophobia
Natural course
Variable: some patients remain stable throughout life; others see their symptoms gradually worsen, especially after the age of 40–50. Familial transmission is possible (autosomal dominant), but sporadic forms are common.
By removing the abnormal 5–10 µm, PTK promotes the regeneration of a more adherent basement membrane. Efficacy: 83–88% of responding eyes recurrence-free at 5 years (Lee 2016, retrospective EBMD study, 58 eyes / 51 patients).
Diagnosis and pre-operative assessment
A complete assessment at the practice prepares you for PTK and determines the best treatment strategy.
Detailed history
Frequency, duration and intensity of morning pain. History of corneal injury, associated dry eye, family history of dystrophy, conservative treatments already tried and for how long.
Slit lamp
Looking for Cogan patterns (fingerprint, map, dots), fluorescein staining to identify areas of defective epithelium, examination of the bandage lens if already in place.
Anterior segment OCT
Epithelial thickness and its variations, appearance of the basement membrane (reduplication, irregularities), anterior stromal thickness to calibrate the ablation depth.
Corneal topography
Detection of irregular astigmatism, identification of topographic asymmetries related to the dystrophy, ruling out keratoconus or early ectasia.
Schirmer test + TBUT
Assessment of concomitant dry eye (tear secretion, tear film stability) — this shapes the post-operative strategy and the prevention of recurrences.
Pachymetry + biometry
Measurement of total corneal thickness, check of anterior chamber depth, axial length if an associated refractive correction is being considered (PTK + PRK).
PTK step by step — excimer laser
PTK is a very quick, precise procedure that restores epithelial adhesion. Here are the steps in detail.
Getting you settled
Anesthetic eye drops (tetracaine or 4% lidocaine) are instilled, followed by rinsing. You are seated comfortably with your head supported. The procedure is painless thanks to topical anesthesia.
Removing the epithelium
Gentle mechanical removal of the epithelium over the treatment zone (6–8 mm in diameter) with a spatula or corneal brush, or after brief application of diluted 20% alcohol followed by rinsing.
Controlled ablation
30 to 60 seconds depending on ablation depth (5–15 µm). Smoothing mode or scanning spot mode. Methylcellulose masking if needed to even out the profile.
Preventing haze
Brief application of 0.02% mitomycin C to limit fibroblast proliferation and the risk of haze, followed by thorough rinsing. Used depending on the depth and the individual risk.
Bandage contact lens
Instillation of topical antibiotics + a topical NSAID, then placement of a soft extended-wear bandage contact lens that protects the cornea during re-epithelialization (3–7 days).
5–10 minutes in the chair
Outpatient procedure, with no corneal flap and no hospital stay. You go home immediately — having someone accompany you is advised, as vision is blurry for the first 24 to 48 hours.
How I perform your PTK
I operate with Schwind and Wavelight excimer lasers, using methylcellulose masking when needed to even out the ablation. The depth calculation is individualized based on the pre-operative OCT: generally 8–12 µm for RCE and 10–15 µm for Cogan dystrophy. 0.02% mitomycin C is used on a case-by-case basis, depending on the ablation depth and the individual risk of haze. A soft extended-wear bandage contact lens is left in place during the re-epithelialization phase.
Close follow-up: check-ups on day 1, day 3 and day 7 to adjust care and detect any complication early, then yearly follow-up to monitor for recurrence.
Recovery — re-epithelialization
Recovery after PTK is well known and predictable. Here is what to expect, day by day.
Intense pain, lens in place
The epithelium is completely absent. You will feel significant eye pain (a scraped sensation), reflex tearing, intense photophobia and very blurry vision. This is normal and temporary. The bandage lens provides a lot of relief. Take oral painkillers (paracetamol/acetaminophen, oral NSAIDs) + NSAID eye drops + antibiotic drops. Avoid bright light. Resting your eyes is recommended.
Gradual improvement, lens removed
The epithelium gradually regenerates. Pain decreases progressively. Vision improves but remains blurry and variable (the new epithelium is still immature). The bandage lens is removed around day 5–7 once complete re-epithelialization has been confirmed. Vision remains blurry for a few more days. Continue the NSAID and antibiotic drops.
Clearer vision, minimal pain
At 2–3 weeks, vision improves significantly and gradually stabilizes. Pain has almost disappeared. The new epithelium consolidates and the basement membrane organizes itself. Light activities can be resumed. NSAID drops can be tapered.
Full stabilization
Vision is stable and clear. The epithelium is mature. No more discomfort. Full return to normal activities (work, sports, going out). Eye drops are usually stopped. Yearly follow-up to monitor for recurrence. The first real test: the next pain-free morning!
Final result
The final result is established. The basement membrane has fully remodeled. Epithelial adhesion is consolidated. The risk of recurrence is very low. Yearly follow-up is recommended to catch any early recurrence.
Results and efficacy — 80–90% lasting success
International studies show that PTK is remarkably effective at eliminating symptoms over the long term.
Estimated probability after successful PTK: 83% (visual symptoms) and 88% (painful erosions). Reference: Lee WS et al. Phototherapeutic keratectomy for epithelial basement membrane dystrophy. Clin Ophthalmol. 2016;11:15-22.
Retrospective study (Stanford): 58 eyes of 51 patients, follow-up of 3 to 170 months. Response in 86.7% of eyes with visual symptoms and 79.3% of eyes with painful erosions.
0.24 logMAR (≈20/32) → 0.07 logMAR (≈20/25) in the 30 eyes with dystrophy-related visual symptoms (Lee 2016).
Usually well tolerated. Major complications remain rare with current techniques.
Criteria for success
Treatment is considered successful if:
- Corneal pain has disappeared or improved markedly
- No painful recurrence ≥3 months after the procedure
- Subjective satisfaction with improved quality of life
- No PTK-related complications
Failure or recurrence
5–15% of patients have a symptomatic recurrence (usually at 6–18 months). Most are re-treated with a second PTK with good results.
Predictors of success
- Well-established diagnosis (confirmed Cogan > idiopathic)
- Failure of conservative treatments for ≥3 months
- Patient adherence to post-operative follow-up
- No concomitant endothelial disease
- Cornea without major anterior scarring
Possible complications (rare)
- Mild stromal haze (~2–5%, prevented by MMC)
- Mild hyperopic shift (~+0.5 D on average)
- Corneal infection (very rare, <1%)
Risks, limitations and contraindications
PTK is a very safe procedure, but you should know the potential risks and limitations before deciding.
- Very short outpatient procedure (5–10 min)
- Local anesthesia only (no sedation)
- Very fast recovery (3–7 days)
- Significantly fewer recurrences (80–90% lasting success at 5 years)
- Preserves corneal transparency
- No corneal flap, no possible ectasia
- Re-treatment possible if it fails
- Major improvement in quality of life
- Marked pain for 24–48 h (epithelium absent) — step 1 or even step 2 painkillers if needed
- Very blurry vision for 3–7 days (duration of re-epithelialization)
- Possible mild stromal haze (~2–5%, prevented by targeted MMC)
- Slight hyperopic shift (≈ +0.25 to +0.5 D depending on depth)
- Failure or recurrence: 5–15% of cases — often re-treatable with a 2nd PTK
- Typical time off work: 5–7 days
- Driving not advised until vision has recovered (≥ 5 days)
- Sports limited for 2–4 weeks (no swimming pools or sea)
- Contact lens wear postponed for at least 1 month
- Systematic UV protection during the healing phase
- Contraindicated if the cornea is fragile (advanced keratoconus) or the endothelium is compromised
- No surgery in case of active corneal infection
- Advanced keratoconus (risk of ectasia, fragile cornea)
- Compromised endothelium (cells < 700/mm², history of a failed graft)
- Active corneal infection (wait for complete healing)
- Major anterior corneal scarring (may hinder re-epithelialization)
- Hypersensitivity to anesthetic products (rare)
Other indications for PTK
Beyond RCE and Cogan dystrophy, PTK has other, less common but validated applications.
Bowman layer dystrophies
PTK can treat symptomatic superficial dystrophies of Bowman's layer: Reis-Bücklers (reticular and geographic opacities of Bowman's layer) and Thiel-Behnke (honeycomb opacities). Laser ablation removes the diseased layer and improves both transparency and surface regularity.
Superficial scars
Small superficial scars after infection or injury may benefit from smoothing PTK to improve transparency. It is not a full transplant, but it can modestly help vision.
Band keratopathy
Nodular calcified deposits in the center of the cornea (mainly anterior), often after trauma. PTK can remove the superficial deposits and improve vision. It is sometimes combined with mechanical debridement.
Combined PTK + PRK
If you have RCE + associated myopia/astigmatism, PTK and PRK can be combined: superficial ablation for the diseased tissue + stromal ablation for the refractive error. A delicate combined approach, but possible in expert hands.
Do you have eye pain in the morning?
Eye pain on waking, recurrent corneal erosions or fluctuating vision? An accurate diagnosis at the practice can determine whether PTK is the right solution for you.
Book a PTK assessment ↗4 steps to lasting relief
Diagnostic consultation
Detailed examination, slit lamp, OCT, topography. Confirmation of the diagnosis (RCE or Cogan). Discussion of the options: PTK or further conservative treatment.
Preparation and consent
Explanation of the technique, risks and benefits. Signing of the informed consent form. Possibly a predictive assessment (OCT image showing the depth to be ablated).
PTK at the practice
5–10 min outpatient procedure. Topical anesthesia, laser, bandage contact lens. A short rest in the chair, then home.
Follow-up and results
Visits on day 1, day 3, day 7 and at 1 month. Lens removal, assessment of re-epithelialization. Yearly post-operative follow-up to anticipate any recurrence.
FAQ — answers to your questions
During the procedure you are under topical anesthesia: you feel the pressure of the laser but no pain. The following 24 to 48 hours are uncomfortable because the epithelium is temporarily absent — the soft bandage contact lens placed at the end of the procedure, oral painkillers and NSAID eye drops provide very good relief. By day 3, there is a clear improvement.
Re-epithelialization takes 3 to 7 days, during which vision is very blurry. By day 7–15, there is a clear improvement. Vision stabilizes and reaches its final level between 3 and 6 months. Patience is needed — it is the price of lasting healing.
It depends on your symptoms. If both eyes are affected and symptomatic, yes — often with an interval of 4 to 6 weeks between the two procedures, to compare results and optimize treatment of the second eye. If only one eye is a problem, treating that eye alone is enough.
No. PTK preserves corneal transparency. The main risk is failure or recurrence (5 to 15%), often treatable with a second session. Serious complications (infection, infiltrates, marked haze) are very rare (< 1%).
Yes, PTK is a CCAM procedure reimbursed by the French national health insurance (Assurance Maladie) when it is indicated for recurrent corneal pain or epithelial dystrophy. A detailed quote is given to you at the pre-operative assessment. Check with your complementary health insurance (mutuelle) regarding coverage of any extra fees.
LASIK corrects refractive errors (myopia, hyperopia, astigmatism) by reshaping the corneal curvature under a flap. PTK, on the other hand, treats a superficial disorder (RCE, Cogan/MDF) by removing ~5–15 µm of cornea, without refractive correction — unless it is combined with PRK to also treat a vision problem.
Yes. If symptoms recur, a second PTK is entirely possible, with good efficacy. Adjusting the post-operative treatment (more intensive lubrication, prevention of micro-injuries) often also helps prevent another recurrence.
When a patient has both a superficial disorder (RCE or Cogan dystrophy) and a refractive error (myopia, astigmatism), PTK + PRK can be combined in a single procedure to treat both. This approach requires a precise ablation calculation, but it is well established. We discuss it at the pre-operative assessment.
Do you suffer from recurrent corneal pain?
If you recognize these symptoms (pain on waking, fluctuating vision, sensitivity to light), a consultation allows me to assess your situation and discuss the best options with you — from conservative treatment to phototherapeutic keratectomy. The goal: pain-free mornings again.
Related pages — learn more
Conditions that are often related or worth exploring after PTK.
Scientific references
This page is based on reference publications in ophthalmology. All sources can be verified via DOI or PubMed.
-
1
Lee WS, Lam CK, Manche EE. Phototherapeutic keratectomy for epithelial basement membrane dystrophy. Clin Ophthalmol. 2016;11:15-22.
-
2
Miller DD, Hasan SA, Simmons NL, Stewart MW. Recurrent corneal erosion: a comprehensive review. Clin Ophthalmol. 2019;13:325-335.
-
3
Wang JC, Remo B, Ramsey D, et al. Phototherapeutic keratectomy for recurrent corneal erosion. Cornea. 2019;38(9):1157-1161.
-
4
Cavanaugh TB, Lind DM, Cutarelli PE, et al. Phototherapeutic keratectomy for recurrent erosion syndrome in anterior basement membrane dystrophy. Ophthalmology. 1999;106(5):971-976.
-
5
Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea. 2000;19(6):767-771.
-
6
Cogan DG, Donaldson DD, Kuwabara T, Marshall D. Microcystic dystrophy of the corneal epithelium. Trans Am Ophthalmol Soc. 1964;62:213-225.
-
7
Sridhar MS. Anatomy of cornea and ocular surface. Indian J Ophthalmol. 2018;66(2):190-194.
The content of this website is for information purposes only and does not replace a medical consultation. Any treatment decision should be made together with your ophthalmologist.